Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: A study among Egyptian patients

Renal Failure

Volumn 36, Issue 2, 2014, Pages 191-197

  Sany, Dawlat ^a   Refaat, Hany ^a   Elshahawy, Yasser ^a   Mohab, Amr ^a   Ezzat, Haitham ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Acute kidney injury; Albuminuria; Diabetes

Indexed keywords

ALBUMIN; CREATININE; IOPROMIDE; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC PATIENT; EGYPT; FEMALE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HUMAN; INCIDENCE; KIDNEY DISEASE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; UREA BLOOD LEVEL; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADULT; AGE FACTORS; AGED; ALBUMINURIA; BLOOD UREA NITROGEN; CARDIAC CATHETERIZATION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS;

EID: 84896699460     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.843400     Document Type: Article

References (38)

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med. 1997;103:368-375.
2. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542-1548.
3. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399.
4. McCullough PA. Beyond serum creatinine: defining the patient with renal insufficiency and why? Rev Cardiovasc Med. 2003; 4(Suppl 1):S2-S6.
5. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409-416.
6. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after coronary interventions. Catheter Cardiovasc Interv. 2001;52:417-419.
7. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399.
8. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515-1519.
9. Bouzas-Mosquera A, Va'zquez-Rodri'guez JM, Calvin?o-Santos R, et al. Contrast induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors, and prognosis [in Spanish]. Rev Esp Cardiol. 2007;60:1026-1034.
10. Herts BR, Schneider E, Poggio ED, et al. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology. 2008;248:106-113.
11. Maioli M, Toso A, Gallopin M, et al. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. J Cardiovasc Med (Hagerstown). 2010;11:444-449.
12. Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of contrast induced nephropathy: recommendationns for the high-risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007;69:135-140.
13. Ghani AA, Tohamy KY. Risk score for contrast induced nephropathy following percutaneous coronary intervention. Saudi J Kidney Dis Transpl. 2009;202:240-245.
14. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-elevation myocardial infarction executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons; endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:652-726.
15. Mangano CM, Diamondstone LS, Ramsay LG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of Postoperative Ischemia Research Group. Ann Intern Med. 1998; 128:194-203.
16. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002; 40:298-303.
17. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329-336.
18. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol. 2002;89:356-358.
19. Solomon R. The role of osmolality in the incidence of contrastinduced nephropathy: a systemic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68:2256-2263.
20. Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333-1340.
21. Rossert J, Fouqueray B. Screening and management of patients with early chronic kidney disease. Acta Diabetol. 2004;41:S6-S12.
22. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention. Circulation. 2001;103: 3019-3041.
23. Vlietstra RE, Nunn CM, Narvarte J, et al. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J. 1996;132:1049-1050.
24. Mason RA, Arbeit LA, Giron F. Renal dysfunction after arteriography. JAMA. 1985;253:1001-1004.
25. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-375.
26. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399.
27. Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89:615-620.
28. Taliercio CP, Vlietstra RE, Fisher LD, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med. 1986;104: 501-504.
29. Miller DL, Chang R, Wells WT, et al. Intravascular contrast media: effect of dose on renal function. Radiology. 1988;167: 607-611.
30. Cruz C, Hricak H, Samhouri F, et al. Contrast media for angiography: effect on renal function. Radiology. 1986;158: 109-112.
31. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast materialinduced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143-149.
32. Roy P, Raya V, Okabe T, et al. Incidence, predictors and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008;101(11):1544-1549.
33. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004; 93(12):1515-1519.
34. Solomon R. The role of osmolality in the incidence of contrastinduced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int. 2005;68(5):2256-2263.
35. Marenzi G. La prevenzione della nefropatia da mezzo di contrasto e la gestione del paziente a rischio. G Ital Cardiol. 2009;10:88-96.
36. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after coronary interventions. Catheter Cardiovasc Interv. 2001;52:417-419.
37. (a). Chen SL, Zhang J, Yei F, et al. Clinical outcomes of contrast induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol. 2008;126:407-413. (b). Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105: 2259-2264.
38. Rudnick MR, Berns JS, Cohen RM, et al. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis. 1994; 24(4):713-727.